Latest filing published 20 Jan 2020 for ArcticZymes Technologies ASA, €21k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -47.4%Entry NOK 11.55 · Close at T+365 NOK 6.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Biotec Pharmacon For: trading record in brief
Biotec Pharmacon For discloses dealings in ArcticZymes Technologies ASA to Oslo Børs. The record holds 7 filings, for trades running from 3 June 2016 to 20 January 2020.
Every open-market trade on record is a purchase: 1 purchase worth €32k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 20 January 2020 came the latest disclosure, a transaction for €21k in ArcticZymes Technologies ASA. The last insider purchase was made public on 3 June 2016, 3,811 days ago. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Biotec Pharmacon For
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares@ NOK 5.30OptionXOSLOSLO:493629
- 30,400 shares@ NOK 4.17OptionXOSLOSLO:469843
- 100,000 shares@ NOK 4.24OptionXOSLOSLO:463556
- 20,000 shares@ NOK 4.42OptionXOSLOSLO:461736
- 20,000 shares@ NOK 4.99OptionXOSLOSLO:457421
- 20,000 shares@ NOK 6.40OptionXOSLOSLO:451597
- 25,187 shares@ NOK 11.87ShareXOSLOSLO:403460Canonical exit: 1 Sept 2016 (T+90)
7 of 7 declarations